{
  "docId": "019de070-a24a-718d-8fa7-de49d427834d",
  "docSlug": "119c472f2b470327a8fb07de55a72f86",
  "documentTitle": "Alkermes | Results Presentation Deck | 15 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 15,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a three-column layout to categorize accomplishments.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a24a-718d-8fa7-de49d427834d/4",
  "deckHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d",
  "deckJsonHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d.json",
  "deckAnchorHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.05,
        "y": 0.32
      },
      "kind": "list",
      "text": "Commercial Execution: VIVITROL and ARISTADA performance, LYBALVI launch prep, VUMERITY support.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32e68489-139a-462a-8f70-16b644edb60c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.67,
        "y": 0.32
      },
      "kind": "list",
      "text": "Management & Governance: COVID-19 cost adaptation, Value Enhancement Plan, Board refreshment.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4bf5c197-1511-450e-a436-c12f8a3d1902",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.36,
        "y": 0.32
      },
      "kind": "list",
      "text": "Advancement of R&D: LYBALVI advisory committee, nemvaleukin alfa progress, HDAC inhibitor candidate.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65330c61-f3d8-4664-b75d-fa052880b932",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.75,
        "x": 0.037,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "*NDA resubmission under review following FDA Complete Response Letter and records requests relating to manufacturing of LYBALVI. **HDAC: histone deacetylase",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e88df40-5082-45fb-a882-fb4ca72e991e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.926,
        "x": 0.037,
        "y": 0.225
      },
      "kind": "title",
      "text": "2020 Key Accomplishments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bec1f75-93fe-4f65-ac63-7514ae3f72de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.037,
        "y": 0.105
      },
      "kind": "title",
      "text": "Execution Against Our Strategic Priorities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e60c93be-138d-4ece-8a9e-e71e9ec098ee",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 4,
      "beatId": "9e89840f-559d-4366-81e6-0e17e754462b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The presentation starts with an overview of Alkermes' strategic priorities",
      "position": 0,
      "confidence": 0.7,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}